Liquidia Technologies (LQDA)
(Delayed Data from NSDQ)
$20.31 USD
+0.24 (1.20%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $20.35 +0.04 (0.20%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Liquidia Technologies, Inc. has a market cap of $1.72B, which represents its share price of $20.07 multiplied by its outstanding shares number of 85.49M. As a small-cap company, LQDA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LQDA 20.31 +0.24(1.20%)
Will LQDA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LQDA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LQDA
Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates
Insmed Stock Jumps 29% on Encouraging PAH Study Results
LQDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates
Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?
Other News for LQDA
Liquidia Corp (LQDA) Announces Upcoming Second Quarter 2025 Financial Results | LQDA stock news
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 | LQDA ...
Liquidia (LQDA) Shares Drop Amid Legal Battle with United Therapeutics
United Therapeutics up 7%, Liquidia down 9% in afternoon trading
Bleecker Street Research short United Therapeutics, long Liquidia